Kristen Bishop
Pediatric Endocrinology · Hoffman Estates, ILNPI 1326297292
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (43.8%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Tolmar, Inc. at 54.0% of the total. 2025 is the largest year on record at $4,246, 4.3 times the $993 reported in 2019.
Across 147 payments — averaging $52.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tolmar, Inc.$4K
- Tandem Diabetes Care, Inc.$503
- Novo Nordisk$463
- AbbVie$355
- Eton Pharmaceuticals, Inc.$245
- Insulet Corporation$229
- plus $2K from 28 others
What the payments were for
- Consulting fees$3,39144%
- Speaking & faculty fees$4005%
- Travel & lodging$3354%
- Food & beverage$3,35843%
- Education$2523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tolmar, Inc. | 12 | $4,177 |
| Tandem Diabetes Care, Inc. | 7 | $503 |
| Novo Nordisk | 26 | $463 |
| AbbVie | 19 | $355 |
| Eton Pharmaceuticals, Inc. | 3 | $245 |
| Insulet Corporation | 4 | $229 |
| Sanofi-aventis U.S. LLC | 3 | $200 |
| Amgen(2 entities) | 11 | $181 |
| Neurocrine Biosciences, Inc. | 3 | $181 |
| Medtronic(2 entities) | 5 | $146 |
| Amarin Pharma, Inc. | 3 | $119 |
| Lilly USA, LLC | 7 | $105 |
| Xeris Pharmaceuticals, Inc. | 4 | $92 |
| AstraZeneca | 2 | $92 |
| Arbor Pharmaceuticals, Inc. | 5 | $78 |
| Boehringer Ingelheim | 4 | $64 |
| Corcept Therapeutics | 3 | $63 |
| Abbott | 3 | $53 |
| BETA Bionics, Inc. | 3 | $50 |
| Pfizer | 2 | $45 |
| Ferring Pharmaceuticals Inc. | 3 | $45 |
| Merck | 2 | $28 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| Vivus LLC | 2 | $21 |
| Recordati_rare_diseases_inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $19 |
| Tolmar Pharmaceuticals, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| Lifescan, Inc. | 1 | $13 |
| Dexcom, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FENSOLVI$3,858
- t:slim X2 insulin pump$400
- Alkindi$195
- CRENESSITY$118
- TZIELD$115
How this compares
$7,735 in reported general payments places this provider in the 75th percentile of 61 pediatric endocrinology providers in Illinois.
Other pediatric endocrinology in Hoffman Estates
- Tseghai BerheHoffman Estates$9K
- Anita SwamyChicago$1.4M
- Stuart KupferDeerfield$196K
- Mary McCauleyWinfield$170K
- Kanika GhaiPark Ridge$139K
- Angela Ganan PopaElk Grove Village$62K
- Courtney FinlaysonChicago$46K
- Stelios MantisChicago$27K
- William ZellerWheaton$15K
- Magdalena DuminPark Ridge$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.